De-duplicating patient records from three independent data sources reveals the incidence of rare neuromuscular disorders in Germany.
Duchenne muscular dystrophy
Incidence
Neuromuscular disease
Spinal muscular atrophy
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
24 06 2019
24 06 2019
Historique:
received:
13
03
2019
accepted:
11
06
2019
entrez:
26
6
2019
pubmed:
27
6
2019
medline:
31
3
2020
Statut:
epublish
Résumé
Estimation of incidence in rare diseases is often challenging due to unspecific and incomplete coding and recording systems. Patient- and health care provider-driven data collections are held with different organizations behind firewalls to protect the privacy of patients. They tend to be fragmented, incomplete and their aggregation leads to further inaccuracies, as the duplicated records cannot easily be identified. We here report about a novel approach to evaluate the incidences of Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA) in Germany. We performed a retrospective epidemiological study collecting data from patients with dystrophinopathies (DMD and Becker muscular dystrophy) and SMA born between 1995 and 2018. We invited all neuromuscular centers, genetic institutes and the patient registries for DMD and SMA in Germany to participate in the data collection. A novel web-based application for data entry was developed converting patient identifying information into a hash code. Duplicate entries were reliably allocated to the distinct patient. We collected 5409 data entries in our web-based database representing 1955 distinct patients with dystrophinopathies and 1287 patients with SMA. 55.0% of distinct patients were found in one of the 3 data sources only, while 32.0% were found in 2, and 13.0% in all 3 data sources. The highest number of SMA patients was reported by genetic testing laboratories, while for DMD the highest number was reported by the clinical specialist centers. After the removal of duplicate records, the highest yearly incidence for DMD was calculated as 2.57:10,000 in 2001 and the highest incidence for SMA as 1.36:10,000 in 2014. With our novel approach (compliant with data protection regulations), we were able to identify unique patient records and estimate the incidence of DMD and SMA in Germany combining and de-duplicating data from patient registries, genetic institutes, and clinical care centers. Although we combined three different data sources, an unknown number of patients might not have been reported by any of these sources. Therefore, our results reflect the minimal incidence of these diseases.
Sections du résumé
BACKGROUND
Estimation of incidence in rare diseases is often challenging due to unspecific and incomplete coding and recording systems. Patient- and health care provider-driven data collections are held with different organizations behind firewalls to protect the privacy of patients. They tend to be fragmented, incomplete and their aggregation leads to further inaccuracies, as the duplicated records cannot easily be identified. We here report about a novel approach to evaluate the incidences of Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA) in Germany.
METHODS
We performed a retrospective epidemiological study collecting data from patients with dystrophinopathies (DMD and Becker muscular dystrophy) and SMA born between 1995 and 2018. We invited all neuromuscular centers, genetic institutes and the patient registries for DMD and SMA in Germany to participate in the data collection. A novel web-based application for data entry was developed converting patient identifying information into a hash code. Duplicate entries were reliably allocated to the distinct patient.
RESULTS
We collected 5409 data entries in our web-based database representing 1955 distinct patients with dystrophinopathies and 1287 patients with SMA. 55.0% of distinct patients were found in one of the 3 data sources only, while 32.0% were found in 2, and 13.0% in all 3 data sources. The highest number of SMA patients was reported by genetic testing laboratories, while for DMD the highest number was reported by the clinical specialist centers. After the removal of duplicate records, the highest yearly incidence for DMD was calculated as 2.57:10,000 in 2001 and the highest incidence for SMA as 1.36:10,000 in 2014.
CONCLUSION
With our novel approach (compliant with data protection regulations), we were able to identify unique patient records and estimate the incidence of DMD and SMA in Germany combining and de-duplicating data from patient registries, genetic institutes, and clinical care centers. Although we combined three different data sources, an unknown number of patients might not have been reported by any of these sources. Therefore, our results reflect the minimal incidence of these diseases.
Identifiants
pubmed: 31234869
doi: 10.1186/s13023-019-1125-2
pii: 10.1186/s13023-019-1125-2
pmc: PMC6591958
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
152Références
Paediatr Child Health. 2018 Feb;23(1):20-26
pubmed: 29479275
Adv Exp Med Biol. 2017;1031:97-124
pubmed: 29214567
Eur J Hum Genet. 2018 Jun;26(6):778-785
pubmed: 29487416
Neuromuscul Disord. 2014 Jun;24(6):482-91
pubmed: 24780148
J Cachexia Sarcopenia Muscle. 2017 Oct;8(5):681-685
pubmed: 29076660
Stud Health Technol Inform. 2016;223:31-8
pubmed: 27139382
IEEE/ACM Trans Comput Biol Bioinform. 2019 Jul-Aug;16(4):1342-1348
pubmed: 30059313
Orphanet J Rare Dis. 2017 Jul 4;12(1):124
pubmed: 28676062
PLoS One. 2014 Jul 17;9(7):e101717
pubmed: 25032825
Orphanet J Rare Dis. 2018 Oct 4;13(1):176
pubmed: 30286784
Orphanet J Rare Dis. 2016 May 04;11(1):58
pubmed: 27145956
Eur J Hum Genet. 2017 Dec;25(12):1293-1302
pubmed: 29158551
Dev Med Child Neurol. 2019 Mar;61(3):292-297
pubmed: 30556126
Hum Mutat. 2013 Nov;34(11):1449-57
pubmed: 23913485
J Neurol. 2017 Jul;264(7):1465-1473
pubmed: 28634652
Ther Adv Neurol Disord. 2018 Feb 05;11:1756285618754501
pubmed: 29434670
Orphanet J Rare Dis. 2013 Oct 23;8:171
pubmed: 24148153